1991 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ying Zhang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Mycobacterium tuberculosis Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
Pyrazinamide Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
Mycobacterium bovis Medicine & Life Sciences
Genes Medicine & Life Sciences
Mutation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

Identification of FDA-approved drugs with activity against stationary phase Bartonella henselae

Li, T., Feng, J., Xiao, S., Shi, W., Sullivan, D. J. & Zhang, Y., Jun 1 2019, In : Antibiotics. 8, 2, 50.

Research output: Contribution to journalArticle

Open Access
Bartonella henselae
Bartonella Infections
Pharmaceutical Preparations

Identification of Genes Regulating Cell Death in Staphylococcus aureus

Yee, R., Feng, J., Wang, J., Chen, J. & Zhang, Y., Oct 1 2019, In : Frontiers in Microbiology. 10, 2199.

Research output: Contribution to journalArticle

Open Access
Staphylococcus aureus
Cell Death
Architectural Accessibility

IL-2 Restores T-Cell Dysfunction Induced by Persistent Mycobacterium tuberculosis Antigen Stimulation

Liu, X., Li, F., Niu, H., Ma, L., Chen, J., Zhang, Y., Peng, L., Gan, C., Ma, X. & Zhu, B., Oct 2 2019, In : Frontiers in immunology. 10, 2350.

Research output: Contribution to journalArticle

Open Access
Mycobacterium tuberculosis

Introducing RpsA point mutations 438A and D123A into the chromosome of mycobacterium tuberculosis confirms their role in causing resistance to pyrazinamide

Shi, W., Cui, P., Niu, H., Zhang, S., Tønjum, T., Zhu, B. & Zhang, Y., Jun 1 2019, In : Antimicrobial agents and chemotherapy. 63, 6, e02681-18.

Research output: Contribution to journalArticle

Mycobacterium tuberculosis
Point Mutation

Pyrazinoic acid inhibits the bifunctional enzyme (Rv2783) in mycobacterium tuberculosis by competing with tmRNA

He, L., Cui, P., Shi, W., Li, Q., Zhang, W., Li, M. & Zhang, Y., Dec 2019, In : Pathogens. 8, 4, 230.

Research output: Contribution to journalArticle

Open Access
Transfer RNA
Mycobacterium tuberculosis
Messenger RNA